News archive search

Search the Newsreel

Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.

Showing
1–36
Matches
179
Sources here
20
Companies here
10
Search results Stored financial headlines

Active search

179 matching headlines

Ticker or company: MEIMain company stories
Clear

Johnson & Johnson Takes $89.72 Billion Position in MeiraGTx Holdings PLC $MGTX

Johnson & Johnson has acquired 6.64 million shares of MeiraGTx Holdings PLC, valued at approximately $89.72 billion, making it J&J's third-largest portfolio holding. This significant investment comes as MeiraGTx reported strong second-quarter earnings, exceeding analyst expectations, and received FDA Breakthrough Therapy Designation for one …

MGTX main company
Sharemaestro market context Trend signal active 52 weeks +72.7% · Next-week setup negative 42.6% MGTX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Profit Surge and New Leadership Might Change The Case For Investing In MeiraGTx Holdings (MGTX)

MeiraGTx Holdings (MGTX) recently reported a significant turnaround in its Q2 2026 financial results, with revenue jumping to US$321.43 million and net income improving to US$160.72 million from a previous loss. This shift to profitability, coupled with new leadership hires experienced in gene therapy …

MGTX main company
Sharemaestro market context Trend signal active 52 weeks +72.7% · Next-week setup negative 42.6% MGTX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Search results

Matching headlines

External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.

Aimei Health Technology Co., Ltd Revenue Breakdown – NASDAQ:AFJK

This article provides a revenue breakdown for Aimei Health Technology Co., Ltd (NASDAQ:AFJK) on TradingView. It offers an overview of the company's financials, including statements, statistics, dividends, earnings, and segments. The page also indicates that segment and regional performance data are available by source …

AFJK main company
Sharemaestro market context Price below Trend Line 52 weeks +8.4% · Next-week setup positive 63.6% AFJK stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Rubric Capital discloses 9.83% MeiraGTx (MGTX) position totaling 9.1M shares

Rubric Capital Management LP and David Rosen have reported a beneficial ownership of 9.83% in MeiraGTx Holdings plc, amounting to 9,100,000 Ordinary Shares. This disclosure was made in an amended Schedule 13G filing, indicating shared voting and dispositive power over these shares, which are …

MGTX main company
Sharemaestro market context Trend signal active 52 weeks +72.7% · Next-week setup negative 42.6% MGTX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

MeiraGTx Holdings Releases Q2 2026 Financial Results

MeiraGTx Holdings plc reported a significant turnaround in Q2 2026, swinging to profitability with diluted earnings per share of $1.71, compared to a loss in the previous year. The company achieved substantial revenue growth, reaching $321.4M from $3.7M in Q2 2025, indicating a commercial …

MGTX main company
Sharemaestro market context Trend signal active 52 weeks +72.7% · Next-week setup negative 42.6% MGTX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Sei Investments Co. Buys Shares of 99,627 MeiraGTx Holdings PLC $MGTX

Sei Investments Co. has acquired 99,627 shares of MeiraGTx Holdings PLC (MGTX) worth approximately $863,000, as part of broader institutional investor interest in the company. Despite significant insider selling totaling $1.68 million over the last three months, MeiraGTx reported strong quarterly EPS of $1.71, …

MGTX main company
Sharemaestro market context Trend signal active 52 weeks +72.7% · Next-week setup negative 42.6% MGTX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Why is MeiraGTx stock surging today?

MeiraGTx Holdings PLC stock surged 6.3% following a dramatic beat on Q2 2026 earnings, reporting $1.71 EPS against an expected loss and revenue of $321.4 million. The company's financial turnaround was supported by strategic deals, FDA Breakthrough Therapy Designation, and a significantly strengthened balance …

MGTX main company
Sharemaestro market context Trend signal active 52 weeks +72.7% · Next-week setup negative 42.6% MGTX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

MeiraGTx Holdings PLC (MGTX) Q2 Earnings and Revenues Surpass Estimates

MeiraGTx Holdings PLC (MGTX) reported Q2 earnings of $1.71 per share, significantly beating the Zacks Consensus Estimate of a loss of $0.39 per share, and revenue of $321.43 million, which also surpassed expectations. Despite the strong quarterly performance, the company holds a Zacks Rank …

MGTX main company
Sharemaestro market context Trend signal active 52 weeks +72.7% · Next-week setup negative 42.6% MGTX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Form 8K MeiraGTx Holdings PLC For: 13 August By Investing.com

This article reports on a Form 8K filing by MeiraGTx Holdings PLC for August 13th, as published by Investing.com. It is a brief announcement without further details regarding the content of the filing. The article is primarily a placeholder for the SEC filing information.

MGTX main company
Sharemaestro market context Trend signal active 52 weeks +72.7% · Next-week setup negative 42.6% MGTX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

MeiraGTx Reports Second Quarter 2026 Financial and Operational Results

MeiraGTx Holdings plc announced its second-quarter 2026 financial and operational results, highlighting significant progress in transforming into a commercial company. Key achievements include the acquisition of botaretigene sparoparvovec (bota-vec) for XLRP, FDA Breakthrough Therapy Designation for AAV2-hAQP1 for radiation-induced xerostomia (RIX) with positive three-year …

MGTX main company
Sharemaestro market context Trend signal active 52 weeks +72.7% · Next-week setup negative 42.6% MGTX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

MeiraGTx Holdings plc 2026: Revenue $321.43M, EPS $1.71— 10-Q Summary

MeiraGTx Holdings plc reported strong financial results for the 2026 quarter, with revenue soaring to $321.43 million and diluted EPS reaching $1.71. This significant growth was primarily driven by increased service and related-party revenue from a Lilly contract, as well as the recognition of …

MGTX main company
Sharemaestro market context Trend signal active 52 weeks +72.7% · Next-week setup negative 42.6% MGTX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

MeiraGTx GAAP EPS of $1.71 beats by $2.15, revenue of $321.4M

* MeiraGTx press release [https://seekingalpha.com/pr/20618173-meiragtx-reports-second-quarter-2026-financial-and-operational-results] (MGTX [https://seekingalpha.com/symbol/MGTX]): Q2 GAAP EPS of $1.71 beats by $2.15. * Revenue of $321.4M (+8610.0% Y/Y). MORE ON MEIRAGTX * Some Potential Merit Within MeiraGTx Holdings [https://seekingalpha.com/article/4927906-some-potential-merit-within-meiragtx-holdings] * MeiraGTx: The Market Is Missing The Manufacturing Pivot [https://seekingalpha.com/article/4918470-meiragtx-the-market-is-missing-the-manufacturing-pivot] * MeiraGTx …

MGTX main company
Sharemaestro market context Trend signal active 52 weeks +72.7% · Next-week setup negative 42.6% MGTX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Aimei Health Technology (AFJK) posts Q2 2026 loss and ends United Hydrogen deal

Aimei Health Technology (AFJK), a SPAC, reported a net loss of $37,704 for the six months ended June 30, 2026, primarily due to operational costs exceeding interest income from its trust account. The company also announced the termination of its previously agreed Business Combination …

AFJK main company
Sharemaestro market context Price below Trend Line 52 weeks +8.4% · Next-week setup positive 63.6% AFJK stored weekly price path from 22 Aug 2025 to 14 Aug 2026

MeiraGTx Holdings PLC (NASDAQ:MGTX) Given Average Rating of "Moderate Buy" by Brokerages

MeiraGTx Holdings PLC (NASDAQ:MGTX) has received an average "Moderate Buy" rating from eight brokerages, with an average 12-month price target of $26.00, significantly above its current trading price of $12.96. Despite recent insider share sales by the CEO and CFO totaling $1.68 million, insiders …

MGTX main company
Sharemaestro market context Trend signal active 52 weeks +72.7% · Next-week setup negative 42.6% MGTX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

BERKLEY W R CORP Exits Aimei Health Technology (AFJK) Entirely: A Case Study in SPAC Risk Management

BERKLEY W R CORP fully divested its position in Aimei Health Technology Co Ltd (AFJK), a SPAC, on June 30, 2026, selling all shares at $30.30. This exit proved timely as AFJK's stock subsequently plummeted by over 60% to $12.01, validating the firm's disciplined …

AFJK main company
Sharemaestro market context Price below Trend Line 52 weeks +8.4% · Next-week setup positive 63.6% AFJK stored weekly price path from 22 Aug 2025 to 14 Aug 2026

AFJK 10-Q & SEC Filings

This article from Yahoo Finance reports on the latest SEC filings for AFJK, specifically its 10-Q periodic financial report. It lists associated exhibits such as EX-31.1, EX-31.2, EX-32.1, and EX-32.2. The article provides a direct link to the SEC Gov filing from June 16, …

AFJK main company
Sharemaestro market context Price below Trend Line 52 weeks +8.4% · Next-week setup positive 63.6% AFJK stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Liquidity Mapping Around (MEI) Price Events

This article analyzes Methode Electronics Inc. (NYSE: MEI) using AI models to provide trading strategies. Key findings indicate strong sentiment across all horizons, supporting an overweight bias, and identifies a significant short setup with an 82.0:1 risk-reward ratio. The analysis offers distinct position, momentum …

MEI main company
Sharemaestro market context Trend signal active 52 weeks +133.3% MEI stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Methode Electronics Inc (MEI) Earnings Forecast: Future EPS & Revenue Growth Estimates

This article provides an earnings forecast for Methode Electronics Inc (MEI), detailing its current earnings forecast score, average price target, and analyst ratings. It highlights that the stock ranks 39 out of 60 in its industry with an average price target of $9.50, and …

MEI main company
Sharemaestro market context Trend signal active 52 weeks +133.3% MEI stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Find financial news

Search the Newsreel

Use one field or combine several. Results are newest first.

Evidence context